申请人:ZENECA LIMITED
公开号:EP0509769A2
公开(公告)日:1992-10-21
The present invention relates to certain novel heterocyclic amides which are 1-pyridylacetamide compounds of formula I, set out herein, which are inhibitors of human leukocyte elastase (HLE), also known as human neutrophil elastase (HNE), making them useful whenever such inhibition is desired, such as for research tools in pharmacological, diagnostic and related studies and in the treatment of diseases in mammals in which HLE is implicated. The invention also includes intermediates useful in the synthesis of these heterocyclic amides, processes for preparing the heterocyclic amides, pharmaceutical compositions containing such heterocyclic amides and methods for their use.
本发明涉及某些新型杂环酰胺,它们是式I的1-吡啶基乙酰胺化合物,载于本发明中,它们是人白细胞弹性蛋白酶(HLE),也称为人中性粒细胞弹性蛋白酶(HNE)的抑制剂,使得它们在任何需要这种抑制的情况下都有用,例如在药理学、诊断学和相关研究中用作研究工具,以及在治疗哺乳动物中涉及HLE的疾病时。本发明还包括用于合成这些杂环酰胺的中间体、制备杂环酰胺的工艺、含有这些杂环酰胺的药物组合物及其使用方法。